StockWhale Sunday, 03/12/17 12:54:43 PM Re: None 0 Post # of 25495 WHY THIS WILL BE BIGGER THAN $OWCP AND $USRM ADDITIONAL NOTES First and Foremost if you haven't yet ACTUALLY READ Prophetable's DD that he did, please do so. This thing is BEYOND undervalued. My own personal EPS Estimate puts this at $5.00 maybe more by EOY. Here are some additional things not covered in Prophetable's DD: Meanweimeraner: Now look up the dates from when the company first announced these strategic investors, pre-clinicals, and uplist to a major exchange... No coincidence that these "health care professionals" are quietly backing this company and its shareholders value just A FEW MONTHS before the 21st century cure act took effect (January 16th 2017) when for the first time stem cell therapies are eligible for FAST TRACK APPROVAL. Hmm. Quite obvious that the company WOULD identify these "strategic investors" if the goal was to "bloat or pump up" $ENDV share value... For all we know this group reps billions...just saying big fish kept anonymous on situations like this. Because if identified PPS would never have seen these lows. For all we know they are not only retiring all convertible debt but ALSO retiring current outstanding shares. Strategic anonymous health care professionals retiring all convertible debt, coincidently announced within a month of 21st century cure act ;) But why let PPS fall so low to retire conversions...? Because they're not just retiring debt... but reducing the float significantly... how else can one be so confident in uplisting to the Nasdaq? Only needs a float of what like 1.5million to meet requirements? ;) with restricted o/s they will also still meet mkt cap requirement. $4.00+ coming no other way to uplist. A R/S WOULD NOT change the mkt cap soooo... If some "accredited health care investor group" is putting up $15-20mil to prop this up to proper valuation then I AM IN. No other way to put it other than they said uplist to a "national exchange". IMO they start throwing money at this now. Wedge broken reversal is here float is on lock down folks now scavenging for shares We will see .06 and see .10 shortly after. Folks will regret passing up on this. More then they regretted $OWCP This is a whole different monster here. This is a rally with CATALYSTS. Not some forward looking b/s THE 21st CENTURY CURE ACT GONNA MAKE US RICH AS SOON AS $ENDV GETS ORPHAN DRUG STATUS. $ENDV OWNS ALL RIGHTS TO ELECTRIC STEM CELL REGENERATION. Boom. Prophetable Additional DD: Looks like they will win their case against New Paradigm for a breach of contract...wonder how much that is for?!? ;) DutchDan: Endonovo Therapeutics (ENDV): Targeting $20+ Billion Market for In Vitro ADME and Toxicology Testing. Here is an Interview with the CEO of $ENDV: https://www.youtube.com/watch?v=mQMRAKWXTsw&t=1s -Article from back when the stock had a 40 million market cap. Quote: Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing bioelectronics-based products and therapies for regenerative medicine. The company is in the process of obtaining an orphan drug designation for its off-the-shelf, allogeneic treatment for Graft-Versus-Host Disease (GvHD), which if successful could see the company's $40 million valuation rise significantly. http://www.4-traders.com/ENDONOVO-THERAPEUTICS-INC-18426319/news/Endonovo-Therapeutics-Inc-Booming-Orphan-Drug-Market-Provides-Investors-with-Massive-Return-Prospe-22090516/ $1.15 target price by SeeThruEquity https://www.youtube.com/watch?v=ijI9SeXP35k Excellent Read: http://seekingalpha.com/article/3997289-upcoming-trials-key-endonovo-time-varying-electromagnetic-fields-technology "Do not let your fire go out, spark by irreplaceable spark in the hopeless swamps of the not-quite, the not-yet, and the not-at-all. Do not let the hero in your soul perish in lonely frustration for the life you deserved."